Normoven 1000 film-coated tablets 1000 mg 30 pcs.

• active ingredient: micronized purified flavonoid fraction/MOFF;
• 1 tablet contains 1000 mg of micronized purified flavonoid fraction, in the form of diosmin and hesperidin (the name hesperidin refers to a mixture of flavonoids: hesperidin, isorhoifolin, linarin, diosmetin) in a ratio of 9:1;
• excipients: microcrystalline cellulose, gelatin, magnesium stearate, sodium starch glycolate (type A), talc, purified water;
• shell: sodium lauryl sulfate; glycerin; Opadry II Orange film coating mixture: (hypromellose (hydroxypropylmethylcellulose); lactose, monohydrate; titanium dioxide (E 171); polyethylene glycol (macrogol); iron oxide yellow (E 172); iron oxide red (E 172).

Hypersensitivity to the active substance or any of the excipients.

When using micronized purified flavonoid fraction, side effects of moderate intensity were observed, mainly from the gastrointestinal tract (diarrhea, dyspepsia, nausea, vomiting).

Nervous system: rarely: dizziness, headache, malaise.

Gastrointestinal disorders: common: diarrhea, dyspepsia, nausea, vomiting; uncommon: colitis; frequency unknown*: abdominal pain

Skin and subcutaneous tissue disorders: rarely: itching, rash, urticaria; frequency unknown*: isolated swelling of the face, lips, eyelids, in exceptional cases – Quincke’s edema.

For oral use. For adult patients.

Venolymphatic insufficiency

The recommended dose of the drug is 1 tablet per day in the morning with a meal.

Hemorrhoid disease

Treatment of acute hemorrhoid episodes: 3 tablets per day for 4 days, then 2 tablets per day for the next 3 days. Take with meals. Divide the daily dose into 2-3 doses. Maintenance therapy – 1 tablet per day.

Treatment course

The duration of therapy is determined by the doctor depending on the indication for use and the course of the disease.

Use during pregnancy or breastfeeding

As a precautionary measure, it is advisable to avoid using the drug during pregnancy.

A decision on whether to discontinue breast-feeding or to discontinue/abstain from therapy with this medicinal product should be made taking into account the benefit of breast-feeding for the child and the benefit of therapy for the mother.

Children

There are no data on the use of Normoven 1000 in children.

Ability to influence reaction speed when driving vehicles or other mechanisms

Studies of the effect of the flavonoid fraction on the ability to drive or operate other mechanisms have not been conducted. However, in accordance with the general safety profile of the flavonoid fraction, Normoven 1000 has no or negligible effect on such ability. Caution should be exercised if side effects of the drug are detected.

Symptoms: There is limited data on cases of overdose with this medicinal product. The most common adverse reactions reported in cases of overdose were gastrointestinal reactions (such as diarrhoea, nausea, abdominal pain) and skin reactions (such as pruritus, rash).

Treatment: Treatment of overdose should include therapy of clinical symptoms.

No interaction studies have been conducted. During post-marketing use of the drug, there have been no reports of any clinically significant drug interactions.

Store in the original packaging at a temperature not exceeding 25C.

Keep out of reach of children.